Orchid Pharma Limited — Important, 30-07-2025: General Updates

Orchid Pharma has acquired 100% share capital of Germany-based Weilchensee 1272. V V GmbH for Euro 28,500 in cash. Renamed Orchid Pharma Europe GmbH, this entity was initially a shelf company with Euro 25,000 paid-up capital and no prior turnover. The acquisition is a strategic move for market expansion, specifically targeting the European market. Though initially an asset management shell, the acquired entity will now operate under the Pharma Sector, signaling Orchid Pharma's intent to broaden its European business footprint.